Senior Director, CT Manufacturing and Materials Management at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Broad functional expertise and knowledge of the supply chain
Knowledge of compliance industry practices (GxP compliance)
Leadership skills to challenge work paradigms, promote continuous improvement, and ensure technical, operational, and GxP excellence

Responsibilities

Develop, oversee, and manage pan-R&D business systems for raw material management (for Drug Substance and Drug Product), Drug Substance supply chains after DS manufacture, and materials management services
Supervise and develop the overall supply network, with deep understanding of capabilities of internal and external partners
Help gather information and set strategy for site selection process in close partnership with QA, Clinical Supply, CMC PM, SMDD, BRD, B358 Manufacturing, DDCS, Procurement, PRD Quality Assurance, and Lilly commercial manufacturing for late Phase assets
Gain leadership alignment on final site sourcing selection
Interface regularly with external business partners through formal and informal meetings to actively manage relationships and ensure an effective and compliant working environment
Accountable for parts of Materials Management across the CT supply chain, including sourcing, management, and operational oversight for raw materials and components used in CMC development and clinical trial material production

Skills

Supply Chain Management

Materials Management

CMC

Manufacturing Oversight

Logistics

Warehousing

Packaging

Labeling

Contract Manufacturing

Drug Product Manufacturing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free